Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan: A Retrospective Cohort Study of Label Compliance

NCT04113551 is registered in ClinicalTrials.gov with Janssen Research & Development, LLC as lead sponsor.

NCT NCT04113551
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04113551 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan: A Retrospective Cohort Study of Label Compliance
Lead sponsor
Janssen Research & Development, LLC
Phase
Observational
Overall status
Completed
Start date
October 1, 2019
Completion date
January 10, 2020
Enrollment
17,418 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit disorder with hyperactivity